FDA Logo links to FDA home pageSkip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule


Antiviral Drugs Advisory Committee

May 19, 2005

Briefing Information

NDA 021-814 APTIVUS (Tipranavir) 250 mg Capsules

Food and Drug Administration Briefing Information htm Word pdf


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Boehringer Ingelheim Briefing Information htm Word pdf

Page updated: May 19, 2005